FDA Approved: COTEMPLA XR-ODT — Original Application (Neos Therapeutics Brands, LLC)

View source ↗

Summary

The FDA approved Cotempla XR-ODT (methylphenidate) through an original NDA for the treatment of attention-deficit/hyperactivity disorder. The product is an exte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• COTEMPLA XR-ODT (METHYLPHENIDATE)

Snippet

ORIG AP for COTEMPLA XR-ODT (METHYLPHENIDATE)